Your browser doesn't support javascript.
loading
One window-period donation in two years of individual donor-nucleic acid test screening for hepatitis B, hepatitis C and human immunodeficiency virus
Levi, Jose Eduardo; Pereira, Ricardo Antonio D'Almeida; Polite, Marcia Bernardino de Carvalho; Mota, Mariza Aparecida; Nunez, Silvia Patricia; Pinho, Joao Renato Rebello; Kutner, Jose Mauro.
Affiliation
  • Levi, Jose Eduardo; Hospital Israelita Albert Einstein - HIAE. Sao Paulo. BR
  • Pereira, Ricardo Antonio D'Almeida; Hospital Israelita Albert Einstein - HIAE. Sao Paulo. BR
  • Polite, Marcia Bernardino de Carvalho; Hospital Israelita Albert Einstein - HIAE. Sao Paulo. BR
  • Mota, Mariza Aparecida; Hospital Israelita Albert Einstein - HIAE. Sao Paulo. BR
  • Nunez, Silvia Patricia; Hospital Israelita Albert Einstein - HIAE. Sao Paulo. BR
  • Pinho, Joao Renato Rebello; Hospital Israelita Albert Einstein - HIAE. Sao Paulo. BR
  • Kutner, Jose Mauro; Hospital Israelita Albert Einstein - HIAE. Sao Paulo. BR
Rev. bras. hematol. hemoter ; Rev. bras. hematol. hemoter;35(3): 167-170, jun. 2013. tab
Article de En | LILACS | ID: lil-681975
Bibliothèque responsable: BR408.1
Localisation: BR408.1
ABSTRACT

Objective:

To describe general data on nucleic acid/serology testing and report the first hepatitis B-nucleic acid testing yield case of an immunized donor in Brazil.

Methods:

A total of 24,441 donations collected in 2010 and 2011 were submitted to individual nucleic acid testing for hepatitis B, hepatitis C and human immunodeficiency virus using the TaqMan® MPX kit (Roche) on the Cobas s201 platform, in addition to routine screening for serological markers. Nucleic acid testing-reactive donations were further evaluated by real-time polymerase chain reaction using Cobas AmpliPrep/Cobas TaqMan hepatitis B virus, hepatitis C virus and human immunodeficiency virus tests.

Results:

Thirty-two donations were reactive by nucleic acid testing, 31 were also serologically reactive and one first-time donor was identified as having hepatitis B in the window period. Follow-up samples showed increasing titers of anti-HBs rising from 19 UI/mL in the index donation to 109 IU/mL seven months later attributable to his vaccination history. Curiously, this donor was never reactive for HbsAg nor for anti-HBc. In the yield donation, he was concomitantly reactive for syphilis (enzyme immunoassay and fluorescent treponemal antibody-absorption; venereal disease research laboratory non-reactive). Overall, six donors (0.02%) were characterized as occult hepatitis B. A total of 35% of the confirmed (recombinant immunoblot assay positive) hepatitis C donations were nucleic acid testing non-reactive and no human ...
Sujet(s)
Mots clés

Texte intégral: 1 Indice: LILACS Sujet Principal: Donneurs de sang / Virus de l'hépatite B / VIH (Virus de l'Immunodéficience Humaine) / Hépatite C / Hepacivirus / RT-PCR / Hépatite B Type d'étude: Diagnostic_studies / Prognostic_studies / Screening_studies Limites du sujet: Female / Humans / Male langue: En Texte intégral: Rev. bras. hematol. hemoter Thème du journal: HEMATOLOGIA Année: 2013 Type: Article

Texte intégral: 1 Indice: LILACS Sujet Principal: Donneurs de sang / Virus de l'hépatite B / VIH (Virus de l'Immunodéficience Humaine) / Hépatite C / Hepacivirus / RT-PCR / Hépatite B Type d'étude: Diagnostic_studies / Prognostic_studies / Screening_studies Limites du sujet: Female / Humans / Male langue: En Texte intégral: Rev. bras. hematol. hemoter Thème du journal: HEMATOLOGIA Année: 2013 Type: Article